nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—Microtubule Inhibition—Docetaxel—skin cancer	0.305	1	CiPCiCtD
Paclitaxel—Docetaxel—skin cancer	0.288	1	CrCtD
Paclitaxel—Cabazitaxel—Docetaxel—skin cancer	0.164	1	CrCrCtD
Paclitaxel—MAP4—Docetaxel—skin cancer	0.022	0.119	CbGbCtD
Paclitaxel—MAPT—Docetaxel—skin cancer	0.0159	0.0861	CbGbCtD
Paclitaxel—MAP2—Docetaxel—skin cancer	0.0159	0.0861	CbGbCtD
Paclitaxel—BCL2—Docetaxel—skin cancer	0.0127	0.0684	CbGbCtD
Paclitaxel—TUBB2B—Docetaxel—skin cancer	0.00727	0.0393	CbGbCtD
Paclitaxel—TUBB4A—Docetaxel—skin cancer	0.00727	0.0393	CbGbCtD
Paclitaxel—TUBB3—Docetaxel—skin cancer	0.00727	0.0393	CbGbCtD
Paclitaxel—TUBB2A—Docetaxel—skin cancer	0.00727	0.0393	CbGbCtD
Paclitaxel—TUBB6—Docetaxel—skin cancer	0.00727	0.0393	CbGbCtD
Paclitaxel—TUBB8—Docetaxel—skin cancer	0.00727	0.0393	CbGbCtD
Paclitaxel—NR1I2—Docetaxel—skin cancer	0.00662	0.0357	CbGbCtD
Paclitaxel—TUBB4B—Docetaxel—skin cancer	0.00608	0.0329	CbGbCtD
Paclitaxel—TUBB1—Docetaxel—skin cancer	0.00608	0.0329	CbGbCtD
Paclitaxel—TUBB—Docetaxel—skin cancer	0.00608	0.0329	CbGbCtD
Paclitaxel—ABCC1—Vemurafenib—skin cancer	0.00523	0.0282	CbGbCtD
Paclitaxel—ABCC10—Docetaxel—skin cancer	0.00465	0.0251	CbGbCtD
Paclitaxel—ABCG2—Vismodegib—skin cancer	0.00443	0.0239	CbGbCtD
Paclitaxel—ABCG2—Vemurafenib—skin cancer	0.0035	0.0189	CbGbCtD
Paclitaxel—ABCC1—Dactinomycin—skin cancer	0.00347	0.0188	CbGbCtD
Paclitaxel—SLCO1B3—Docetaxel—skin cancer	0.00259	0.014	CbGbCtD
Paclitaxel—CYP1B1—Docetaxel—skin cancer	0.00253	0.0136	CbGbCtD
Paclitaxel—CYP2C8—Vismodegib—skin cancer	0.00236	0.0127	CbGbCtD
Paclitaxel—ABCG2—Dactinomycin—skin cancer	0.00232	0.0126	CbGbCtD
Paclitaxel—ABCC1—Docetaxel—skin cancer	0.00179	0.00969	CbGbCtD
Paclitaxel—CYP2C9—Vismodegib—skin cancer	0.00164	0.00888	CbGbCtD
Paclitaxel—ABCB1—Vismodegib—skin cancer	0.0016	0.00862	CbGbCtD
Paclitaxel—ABCG2—Fluorouracil—skin cancer	0.00157	0.00849	CbGbCtD
Paclitaxel—CYP3A4—Temozolomide—skin cancer	0.00138	0.00745	CbGbCtD
Paclitaxel—CYP3A4—Imiquimod—skin cancer	0.00138	0.00745	CbGbCtD
Paclitaxel—ABCC2—Docetaxel—skin cancer	0.00133	0.00717	CbGbCtD
Paclitaxel—ABCG2—Docetaxel—skin cancer	0.0012	0.00649	CbGbCtD
Paclitaxel—CYP3A4—Vismodegib—skin cancer	0.000956	0.00517	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.000887	0.00479	CbGbCtD
Paclitaxel—CYP3A7—Docetaxel—skin cancer	0.000887	0.00479	CbGbCtD
Paclitaxel—ABCB1—Dactinomycin—skin cancer	0.000838	0.00453	CbGbCtD
Paclitaxel—CYP2C8—Fluorouracil—skin cancer	0.000837	0.00452	CbGbCtD
Paclitaxel—CYP3A4—Vemurafenib—skin cancer	0.000756	0.00408	CbGbCtD
Paclitaxel—CYP3A5—Docetaxel—skin cancer	0.000665	0.00359	CbGbCtD
Paclitaxel—CYP2C9—Fluorouracil—skin cancer	0.000584	0.00316	CbGbCtD
Paclitaxel—MAP4—hair follicle—skin cancer	0.000488	0.0389	CbGeAlD
Paclitaxel—MAP2—nerve—skin cancer	0.000459	0.0366	CbGeAlD
Paclitaxel—ABCB1—Docetaxel—skin cancer	0.000433	0.00234	CbGbCtD
Paclitaxel—TUBB4B—Sorafenib—Vismodegib—skin cancer	0.000416	0.667	CbGdCrCtD
Paclitaxel—TUBB4B—skin epidermis—skin cancer	0.000325	0.0259	CbGeAlD
Paclitaxel—BCL2—neck—skin cancer	0.000298	0.0237	CbGeAlD
Paclitaxel—TUBB—hair follicle—skin cancer	0.000272	0.0216	CbGeAlD
Paclitaxel—MAP2—nipple—skin cancer	0.000261	0.0208	CbGeAlD
Paclitaxel—CYP3A4—Docetaxel—skin cancer	0.000259	0.0014	CbGbCtD
Paclitaxel—MAP2—neck—skin cancer	0.000258	0.0205	CbGeAlD
Paclitaxel—TUBB3—connective tissue—skin cancer	0.000235	0.0187	CbGeAlD
Paclitaxel—MAP4—connective tissue—skin cancer	0.000235	0.0187	CbGeAlD
Paclitaxel—TUBB4B—hair follicle—skin cancer	0.000232	0.0184	CbGeAlD
Paclitaxel—BCL2—connective tissue—skin cancer	0.000213	0.017	CbGeAlD
Paclitaxel—MAP4—skin of body—skin cancer	0.000212	0.0169	CbGeAlD
Paclitaxel—NR1I2—head—skin cancer	0.000212	0.0168	CbGeAlD
Paclitaxel—TUBB6—Sorafenib—Vismodegib—skin cancer	0.000207	0.333	CbGdCrCtD
Paclitaxel—TUBB8—head—skin cancer	0.000203	0.0161	CbGeAlD
Paclitaxel—BCL2—epithelium—skin cancer	0.000203	0.0161	CbGeAlD
Paclitaxel—TUBB2B—nipple—skin cancer	0.000195	0.0155	CbGeAlD
Paclitaxel—BCL2—skin of body—skin cancer	0.000193	0.0153	CbGeAlD
Paclitaxel—TUBB—nipple—skin cancer	0.000184	0.0147	CbGeAlD
Paclitaxel—CYP1B1—hair follicle—skin cancer	0.000184	0.0146	CbGeAlD
Paclitaxel—TUBB2A—nipple—skin cancer	0.000183	0.0146	CbGeAlD
Paclitaxel—TUBB6—nipple—skin cancer	0.000181	0.0144	CbGeAlD
Paclitaxel—MAP4—lymphoid tissue—skin cancer	0.000172	0.0137	CbGeAlD
Paclitaxel—TUBB3—lymphoid tissue—skin cancer	0.000172	0.0137	CbGeAlD
Paclitaxel—MAP4—female reproductive system—skin cancer	0.000166	0.0132	CbGeAlD
Paclitaxel—ABCC1—hair follicle—skin cancer	0.000165	0.0131	CbGeAlD
Paclitaxel—ABCC10—nipple—skin cancer	0.000158	0.0126	CbGeAlD
Paclitaxel—TUBB4B—nipple—skin cancer	0.000157	0.0125	CbGeAlD
Paclitaxel—BCL2—lymphoid tissue—skin cancer	0.000156	0.0124	CbGeAlD
Paclitaxel—MAP2—mammalian vulva—skin cancer	0.000152	0.0121	CbGeAlD
Paclitaxel—BCL2—female reproductive system—skin cancer	0.000151	0.012	CbGeAlD
Paclitaxel—TUBB4A—connective tissue—skin cancer	0.000143	0.0114	CbGeAlD
Paclitaxel—MAP4—head—skin cancer	0.000138	0.011	CbGeAlD
Paclitaxel—TUBB3—head—skin cancer	0.000138	0.011	CbGeAlD
Paclitaxel—TUBB2B—connective tissue—skin cancer	0.000138	0.011	CbGeAlD
Paclitaxel—TUBB1—head—skin cancer	0.000135	0.0108	CbGeAlD
Paclitaxel—MAP2—female reproductive system—skin cancer	0.00013	0.0104	CbGeAlD
Paclitaxel—TUBB2A—connective tissue—skin cancer	0.00013	0.0103	CbGeAlD
Paclitaxel—TUBB4A—skin of body—skin cancer	0.000129	0.0103	CbGeAlD
Paclitaxel—BCL2—head—skin cancer	0.000126	0.01	CbGeAlD
Paclitaxel—MAPT—lymph node—skin cancer	0.000123	0.00981	CbGeAlD
Paclitaxel—TUBB6—epithelium—skin cancer	0.000122	0.00969	CbGeAlD
Paclitaxel—TUBB2A—skin of body—skin cancer	0.000117	0.00934	CbGeAlD
Paclitaxel—TUBB6—skin of body—skin cancer	0.000116	0.00921	CbGeAlD
Paclitaxel—TUBB2B—mammalian vulva—skin cancer	0.000114	0.00905	CbGeAlD
Paclitaxel—ABCC1—nipple—skin cancer	0.000112	0.00891	CbGeAlD
Paclitaxel—TUBB4B—connective tissue—skin cancer	0.000111	0.00887	CbGeAlD
Paclitaxel—MAP2—head—skin cancer	0.000109	0.00867	CbGeAlD
Paclitaxel—TUBB—mammalian vulva—skin cancer	0.000108	0.00857	CbGeAlD
Paclitaxel—TUBB2A—mammalian vulva—skin cancer	0.000107	0.00852	CbGeAlD
Paclitaxel—TUBB6—mammalian vulva—skin cancer	0.000106	0.0084	CbGeAlD
Paclitaxel—TUBB4A—lymphoid tissue—skin cancer	0.000105	0.00832	CbGeAlD
Paclitaxel—TUBB4A—female reproductive system—skin cancer	0.000101	0.00802	CbGeAlD
Paclitaxel—TUBB4B—skin of body—skin cancer	0.000101	0.00801	CbGeAlD
Paclitaxel—TUBB2B—female reproductive system—skin cancer	9.74e-05	0.00775	CbGeAlD
Paclitaxel—MAP4—lymph node—skin cancer	9.69e-05	0.00771	CbGeAlD
Paclitaxel—CYP19A1—connective tissue—skin cancer	9.44e-05	0.00752	CbGeAlD
Paclitaxel—TUBB6—lymphoid tissue—skin cancer	9.38e-05	0.00746	CbGeAlD
Paclitaxel—ABCC10—mammalian vulva—skin cancer	9.25e-05	0.00736	CbGeAlD
Paclitaxel—TUBB4B—mammalian vulva—skin cancer	9.18e-05	0.00731	CbGeAlD
Paclitaxel—TUBB2A—female reproductive system—skin cancer	9.17e-05	0.0073	CbGeAlD
Paclitaxel—TUBB6—female reproductive system—skin cancer	9.04e-05	0.0072	CbGeAlD
Paclitaxel—CYP1B1—connective tissue—skin cancer	8.83e-05	0.00703	CbGeAlD
Paclitaxel—BCL2—lymph node—skin cancer	8.81e-05	0.00701	CbGeAlD
Paclitaxel—TUBB4A—head—skin cancer	8.42e-05	0.0067	CbGeAlD
Paclitaxel—ABCC10—lymphoid tissue—skin cancer	8.21e-05	0.00653	CbGeAlD
Paclitaxel—TUBB4B—lymphoid tissue—skin cancer	8.15e-05	0.00649	CbGeAlD
Paclitaxel—TUBB2B—head—skin cancer	8.14e-05	0.00648	CbGeAlD
Paclitaxel—CYP1B1—skin of body—skin cancer	7.97e-05	0.00634	CbGeAlD
Paclitaxel—ABCC10—female reproductive system—skin cancer	7.92e-05	0.0063	CbGeAlD
Paclitaxel—TUBB4B—female reproductive system—skin cancer	7.86e-05	0.00626	CbGeAlD
Paclitaxel—TUBB2A—head—skin cancer	7.66e-05	0.0061	CbGeAlD
Paclitaxel—MAP2—lymph node—skin cancer	7.63e-05	0.00607	CbGeAlD
Paclitaxel—TUBB6—head—skin cancer	7.56e-05	0.00601	CbGeAlD
Paclitaxel—CYP19A1—female reproductive system—skin cancer	6.66e-05	0.0053	CbGeAlD
Paclitaxel—TUBB4B—head—skin cancer	6.57e-05	0.00523	CbGeAlD
Paclitaxel—ABCC1—mammalian vulva—skin cancer	6.54e-05	0.0052	CbGeAlD
Paclitaxel—CYP1B1—lymphoid tissue—skin cancer	6.46e-05	0.00514	CbGeAlD
Paclitaxel—ABCC2—female reproductive system—skin cancer	6.36e-05	0.00506	CbGeAlD
Paclitaxel—ABCB1—blood vessel—skin cancer	6.32e-05	0.00503	CbGeAlD
Paclitaxel—CYP1B1—female reproductive system—skin cancer	6.23e-05	0.00496	CbGeAlD
Paclitaxel—TUBB4A—lymph node—skin cancer	5.9e-05	0.00469	CbGeAlD
Paclitaxel—TUBB2B—lymph node—skin cancer	5.7e-05	0.00453	CbGeAlD
Paclitaxel—CYP19A1—head—skin cancer	5.56e-05	0.00443	CbGeAlD
Paclitaxel—ABCG2—mammalian vulva—skin cancer	5.41e-05	0.00431	CbGeAlD
Paclitaxel—TUBB—lymph node—skin cancer	5.39e-05	0.00429	CbGeAlD
Paclitaxel—TUBB2A—lymph node—skin cancer	5.36e-05	0.00427	CbGeAlD
Paclitaxel—TUBB6—lymph node—skin cancer	5.29e-05	0.00421	CbGeAlD
Paclitaxel—CYP1B1—head—skin cancer	5.2e-05	0.00414	CbGeAlD
Paclitaxel—CYP2C8—female reproductive system—skin cancer	4.77e-05	0.00379	CbGeAlD
Paclitaxel—ABCC10—lymph node—skin cancer	4.63e-05	0.00369	CbGeAlD
Paclitaxel—TUBB4B—lymph node—skin cancer	4.6e-05	0.00366	CbGeAlD
Paclitaxel—CYP2C9—female reproductive system—skin cancer	4.24e-05	0.00337	CbGeAlD
Paclitaxel—CYP19A1—lymph node—skin cancer	3.9e-05	0.0031	CbGeAlD
Paclitaxel—ABCC2—lymph node—skin cancer	3.72e-05	0.00296	CbGeAlD
Paclitaxel—CYP1B1—lymph node—skin cancer	3.64e-05	0.0029	CbGeAlD
Paclitaxel—ABCC1—lymph node—skin cancer	3.28e-05	0.00261	CbGeAlD
Paclitaxel—CYP3A4—female reproductive system—skin cancer	3.23e-05	0.00257	CbGeAlD
Paclitaxel—ABCB1—epithelium—skin cancer	3.08e-05	0.00245	CbGeAlD
Paclitaxel—ABCG2—lymph node—skin cancer	2.71e-05	0.00216	CbGeAlD
Paclitaxel—ABCB1—mammalian vulva—skin cancer	2.67e-05	0.00212	CbGeAlD
Paclitaxel—BCL2—IL2 signaling events mediated by PI3K—TERT—skin cancer	2.51e-05	0.0123	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—XRCC3—skin cancer	2.47e-05	0.0121	CbGpPWpGaD
Paclitaxel—MAP2—LKB1 signaling events—TP53—skin cancer	2.46e-05	0.012	CbGpPWpGaD
Paclitaxel—ABCB1—lymphoid tissue—skin cancer	2.37e-05	0.00189	CbGeAlD
Paclitaxel—ABCB1—female reproductive system—skin cancer	2.29e-05	0.00182	CbGeAlD
Paclitaxel—MAPT—MAPK Signaling Pathway—RASA1—skin cancer	2.22e-05	0.0109	CbGpPWpGaD
Paclitaxel—Malnutrition—Temozolomide—skin cancer	2.03e-05	0.000478	CcSEcCtD
Paclitaxel—Breast disorder—Docetaxel—skin cancer	2.02e-05	0.000477	CcSEcCtD
Paclitaxel—Discomfort—Bleomycin—skin cancer	2.02e-05	0.000476	CcSEcCtD
Paclitaxel—Malaise—Dactinomycin—skin cancer	2.02e-05	0.000476	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.02e-05	0.00988	CbGpPWpGaD
Paclitaxel—Cramp muscle—Docetaxel—skin cancer	2.02e-05	0.000475	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Docetaxel—skin cancer	2.02e-05	0.000475	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Docetaxel—skin cancer	2.02e-05	0.000475	CcSEcCtD
Paclitaxel—Leukopenia—Dactinomycin—skin cancer	2.01e-05	0.000473	CcSEcCtD
Paclitaxel—Nasopharyngitis—Docetaxel—skin cancer	2e-05	0.000472	CcSEcCtD
Paclitaxel—Dysgeusia—Temozolomide—skin cancer	1.99e-05	0.000468	CcSEcCtD
Paclitaxel—Asthenia—Imiquimod—skin cancer	1.98e-05	0.000467	CcSEcCtD
Paclitaxel—Confusional state—Bleomycin—skin cancer	1.98e-05	0.000466	CcSEcCtD
Paclitaxel—Alanine aminotransferase increased—Docetaxel—skin cancer	1.97e-05	0.000465	CcSEcCtD
Paclitaxel—Oedema—Bleomycin—skin cancer	1.96e-05	0.000462	CcSEcCtD
Paclitaxel—Anaphylactic shock—Bleomycin—skin cancer	1.96e-05	0.000462	CcSEcCtD
Paclitaxel—Back pain—Temozolomide—skin cancer	1.96e-05	0.000462	CcSEcCtD
Paclitaxel—BCL2—Integrated Cancer Pathway—CDK4—skin cancer	1.96e-05	0.00958	CbGpPWpGaD
Paclitaxel—Pruritus—Imiquimod—skin cancer	1.95e-05	0.00046	CcSEcCtD
Paclitaxel—Infection—Bleomycin—skin cancer	1.95e-05	0.000459	CcSEcCtD
Paclitaxel—Dysphagia—Docetaxel—skin cancer	1.94e-05	0.000456	CcSEcCtD
Paclitaxel—Nausea—Vemurafenib—skin cancer	1.92e-05	0.000453	CcSEcCtD
Paclitaxel—Thrombocytopenia—Bleomycin—skin cancer	1.92e-05	0.000452	CcSEcCtD
Paclitaxel—Arrhythmia—Fluorouracil—skin cancer	1.92e-05	0.000452	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.91e-05	0.00936	CbGpPWpGaD
Paclitaxel—Vision blurred—Temozolomide—skin cancer	1.91e-05	0.00045	CcSEcCtD
Paclitaxel—ABCB1—head—skin cancer	1.91e-05	0.00152	CbGeAlD
Paclitaxel—Myalgia—Dactinomycin—skin cancer	1.91e-05	0.000449	CcSEcCtD
Paclitaxel—Tremor—Temozolomide—skin cancer	1.9e-05	0.000447	CcSEcCtD
Paclitaxel—Alopecia—Fluorouracil—skin cancer	1.9e-05	0.000447	CcSEcCtD
Paclitaxel—Diarrhoea—Imiquimod—skin cancer	1.89e-05	0.000445	CcSEcCtD
Paclitaxel—Discomfort—Dactinomycin—skin cancer	1.89e-05	0.000444	CcSEcCtD
Paclitaxel—Ill-defined disorder—Temozolomide—skin cancer	1.88e-05	0.000443	CcSEcCtD
Paclitaxel—Anaemia—Temozolomide—skin cancer	1.87e-05	0.000441	CcSEcCtD
Paclitaxel—Anorexia—Bleomycin—skin cancer	1.87e-05	0.00044	CcSEcCtD
Paclitaxel—Erythema—Fluorouracil—skin cancer	1.87e-05	0.00044	CcSEcCtD
Paclitaxel—Agitation—Temozolomide—skin cancer	1.86e-05	0.000439	CcSEcCtD
Paclitaxel—Angioedema—Temozolomide—skin cancer	1.85e-05	0.000436	CcSEcCtD
Paclitaxel—Pancytopenia—Docetaxel—skin cancer	1.84e-05	0.000433	CcSEcCtD
Paclitaxel—Hypotension—Bleomycin—skin cancer	1.83e-05	0.000432	CcSEcCtD
Paclitaxel—Oedema—Dactinomycin—skin cancer	1.83e-05	0.000431	CcSEcCtD
Paclitaxel—Malaise—Temozolomide—skin cancer	1.83e-05	0.000431	CcSEcCtD
Paclitaxel—Dizziness—Imiquimod—skin cancer	1.83e-05	0.00043	CcSEcCtD
Paclitaxel—Vertigo—Temozolomide—skin cancer	1.82e-05	0.000429	CcSEcCtD
Paclitaxel—Infection—Dactinomycin—skin cancer	1.82e-05	0.000428	CcSEcCtD
Paclitaxel—Leukopenia—Temozolomide—skin cancer	1.81e-05	0.000427	CcSEcCtD
Paclitaxel—Neutropenia—Docetaxel—skin cancer	1.81e-05	0.000426	CcSEcCtD
Paclitaxel—Palpitations—Temozolomide—skin cancer	1.79e-05	0.000422	CcSEcCtD
Paclitaxel—Thrombocytopenia—Dactinomycin—skin cancer	1.79e-05	0.000422	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Bleomycin—skin cancer	1.79e-05	0.000421	CcSEcCtD
Paclitaxel—Cough—Temozolomide—skin cancer	1.77e-05	0.000417	CcSEcCtD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.76e-05	0.00862	CbGpPWpGaD
Paclitaxel—Paraesthesia—Bleomycin—skin cancer	1.76e-05	0.000415	CcSEcCtD
Paclitaxel—Weight increased—Docetaxel—skin cancer	1.76e-05	0.000415	CcSEcCtD
Paclitaxel—Vision blurred—Fluorouracil—skin cancer	1.76e-05	0.000415	CcSEcCtD
Paclitaxel—Convulsion—Temozolomide—skin cancer	1.76e-05	0.000414	CcSEcCtD
Paclitaxel—Vomiting—Imiquimod—skin cancer	1.76e-05	0.000413	CcSEcCtD
Paclitaxel—Weight decreased—Docetaxel—skin cancer	1.75e-05	0.000412	CcSEcCtD
Paclitaxel—Hypertension—Temozolomide—skin cancer	1.75e-05	0.000412	CcSEcCtD
Paclitaxel—Dyspnoea—Bleomycin—skin cancer	1.75e-05	0.000412	CcSEcCtD
Paclitaxel—Anorexia—Dactinomycin—skin cancer	1.74e-05	0.000411	CcSEcCtD
Paclitaxel—Rash—Imiquimod—skin cancer	1.74e-05	0.00041	CcSEcCtD
Paclitaxel—Dermatitis—Imiquimod—skin cancer	1.74e-05	0.00041	CcSEcCtD
Paclitaxel—Pneumonia—Docetaxel—skin cancer	1.74e-05	0.000409	CcSEcCtD
Paclitaxel—Headache—Imiquimod—skin cancer	1.73e-05	0.000407	CcSEcCtD
Paclitaxel—Anaemia—Fluorouracil—skin cancer	1.73e-05	0.000407	CcSEcCtD
Paclitaxel—Arthralgia—Temozolomide—skin cancer	1.73e-05	0.000407	CcSEcCtD
Paclitaxel—Myalgia—Temozolomide—skin cancer	1.73e-05	0.000407	CcSEcCtD
Paclitaxel—Infestation—Docetaxel—skin cancer	1.73e-05	0.000406	CcSEcCtD
Paclitaxel—Infestation NOS—Docetaxel—skin cancer	1.73e-05	0.000406	CcSEcCtD
Paclitaxel—Anxiety—Temozolomide—skin cancer	1.72e-05	0.000405	CcSEcCtD
Paclitaxel—ABCC1—S1P1 pathway—PTGS2—skin cancer	1.72e-05	0.00841	CbGpPWpGaD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	1.71e-05	0.000404	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Docetaxel—skin cancer	1.71e-05	0.000403	CcSEcCtD
Paclitaxel—Discomfort—Temozolomide—skin cancer	1.71e-05	0.000402	CcSEcCtD
Paclitaxel—Decreased appetite—Bleomycin—skin cancer	1.71e-05	0.000402	CcSEcCtD
Paclitaxel—Acute coronary syndrome—Docetaxel—skin cancer	1.7e-05	0.000401	CcSEcCtD
Paclitaxel—Renal failure—Docetaxel—skin cancer	1.7e-05	0.000399	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—MSH2—skin cancer	1.69e-05	0.00828	CbGpPWpGaD
Paclitaxel—Neuropathy peripheral—Docetaxel—skin cancer	1.69e-05	0.000398	CcSEcCtD
Paclitaxel—Myocardial infarction—Docetaxel—skin cancer	1.69e-05	0.000398	CcSEcCtD
Paclitaxel—Dry mouth—Temozolomide—skin cancer	1.69e-05	0.000398	CcSEcCtD
Paclitaxel—Stomatitis—Docetaxel—skin cancer	1.68e-05	0.000396	CcSEcCtD
Paclitaxel—Pain—Bleomycin—skin cancer	1.68e-05	0.000395	CcSEcCtD
Paclitaxel—Conjunctivitis—Docetaxel—skin cancer	1.68e-05	0.000395	CcSEcCtD
Paclitaxel—Leukopenia—Fluorouracil—skin cancer	1.67e-05	0.000394	CcSEcCtD
Paclitaxel—Confusional state—Temozolomide—skin cancer	1.67e-05	0.000393	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Dactinomycin—skin cancer	1.67e-05	0.000393	CcSEcCtD
Paclitaxel—Oedema—Temozolomide—skin cancer	1.65e-05	0.00039	CcSEcCtD
Paclitaxel—Anaphylactic shock—Temozolomide—skin cancer	1.65e-05	0.00039	CcSEcCtD
Paclitaxel—Infection—Temozolomide—skin cancer	1.64e-05	0.000387	CcSEcCtD
Paclitaxel—MAPT—IL-5 Signaling Pathway—KRAS—skin cancer	1.64e-05	0.00805	CbGpPWpGaD
Paclitaxel—Nausea—Imiquimod—skin cancer	1.64e-05	0.000386	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Docetaxel—skin cancer	1.63e-05	0.000384	CcSEcCtD
Paclitaxel—BCL2—TP53 Network—TP53—skin cancer	1.63e-05	0.00798	CbGpPWpGaD
Paclitaxel—Epistaxis—Docetaxel—skin cancer	1.63e-05	0.000383	CcSEcCtD
Paclitaxel—Nervous system disorder—Temozolomide—skin cancer	1.62e-05	0.000382	CcSEcCtD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	1.62e-05	0.00793	CbGpPWpGaD
Paclitaxel—Thrombocytopenia—Temozolomide—skin cancer	1.62e-05	0.000382	CcSEcCtD
Paclitaxel—Convulsion—Fluorouracil—skin cancer	1.62e-05	0.000381	CcSEcCtD
Paclitaxel—Feeling abnormal—Bleomycin—skin cancer	1.62e-05	0.000381	CcSEcCtD
Paclitaxel—Skin disorder—Temozolomide—skin cancer	1.61e-05	0.000379	CcSEcCtD
Paclitaxel—Hyperhidrosis—Temozolomide—skin cancer	1.6e-05	0.000377	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—MSH2—skin cancer	1.59e-05	0.0078	CbGpPWpGaD
Paclitaxel—Myalgia—Fluorouracil—skin cancer	1.59e-05	0.000375	CcSEcCtD
Paclitaxel—Chest pain—Fluorouracil—skin cancer	1.59e-05	0.000375	CcSEcCtD
Paclitaxel—Decreased appetite—Dactinomycin—skin cancer	1.59e-05	0.000375	CcSEcCtD
Paclitaxel—CYP19A1—Ovarian Infertility Genes—CDK4—skin cancer	1.59e-05	0.00779	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	1.58e-05	0.00774	CbGpPWpGaD
Paclitaxel—Fatigue—Dactinomycin—skin cancer	1.58e-05	0.000371	CcSEcCtD
Paclitaxel—Anorexia—Temozolomide—skin cancer	1.58e-05	0.000371	CcSEcCtD
Paclitaxel—Discomfort—Fluorouracil—skin cancer	1.57e-05	0.00037	CcSEcCtD
Paclitaxel—Pain—Dactinomycin—skin cancer	1.56e-05	0.000368	CcSEcCtD
Paclitaxel—Urticaria—Bleomycin—skin cancer	1.56e-05	0.000367	CcSEcCtD
Paclitaxel—Haemoglobin—Docetaxel—skin cancer	1.56e-05	0.000367	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	1.56e-05	0.00762	CbGpPWpGaD
Paclitaxel—Rhinitis—Docetaxel—skin cancer	1.55e-05	0.000366	CcSEcCtD
Paclitaxel—Body temperature increased—Bleomycin—skin cancer	1.55e-05	0.000365	CcSEcCtD
Paclitaxel—Haemorrhage—Docetaxel—skin cancer	1.55e-05	0.000365	CcSEcCtD
Paclitaxel—BCL2—ATF-2 transcription factor network—CDK4—skin cancer	1.55e-05	0.00758	CbGpPWpGaD
Paclitaxel—Hypoaesthesia—Docetaxel—skin cancer	1.54e-05	0.000363	CcSEcCtD
Paclitaxel—Confusional state—Fluorouracil—skin cancer	1.54e-05	0.000362	CcSEcCtD
Paclitaxel—Pharyngitis—Docetaxel—skin cancer	1.54e-05	0.000362	CcSEcCtD
Paclitaxel—Urinary tract disorder—Docetaxel—skin cancer	1.53e-05	0.00036	CcSEcCtD
Paclitaxel—Oedema peripheral—Docetaxel—skin cancer	1.53e-05	0.000359	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—MLH1—skin cancer	1.52e-05	0.00747	CbGpPWpGaD
Paclitaxel—Anaphylactic shock—Fluorouracil—skin cancer	1.52e-05	0.000359	CcSEcCtD
Paclitaxel—Oedema—Fluorouracil—skin cancer	1.52e-05	0.000359	CcSEcCtD
Paclitaxel—Connective tissue disorder—Docetaxel—skin cancer	1.52e-05	0.000358	CcSEcCtD
Paclitaxel—Urethral disorder—Docetaxel—skin cancer	1.52e-05	0.000358	CcSEcCtD
Paclitaxel—Infection—Fluorouracil—skin cancer	1.51e-05	0.000357	CcSEcCtD
Paclitaxel—Feeling abnormal—Dactinomycin—skin cancer	1.51e-05	0.000355	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Temozolomide—skin cancer	1.51e-05	0.000355	CcSEcCtD
Paclitaxel—Insomnia—Temozolomide—skin cancer	1.5e-05	0.000352	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dactinomycin—skin cancer	1.5e-05	0.000352	CcSEcCtD
Paclitaxel—Nervous system disorder—Fluorouracil—skin cancer	1.5e-05	0.000352	CcSEcCtD
Paclitaxel—Thrombocytopenia—Fluorouracil—skin cancer	1.49e-05	0.000352	CcSEcCtD
Paclitaxel—Visual impairment—Docetaxel—skin cancer	1.49e-05	0.000352	CcSEcCtD
Paclitaxel—BCL2—Overview of nanoparticle effects—IL6—skin cancer	1.49e-05	0.0073	CbGpPWpGaD
Paclitaxel—Tachycardia—Fluorouracil—skin cancer	1.49e-05	0.00035	CcSEcCtD
Paclitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	1.49e-05	0.00728	CbGpPWpGaD
Paclitaxel—Paraesthesia—Temozolomide—skin cancer	1.49e-05	0.00035	CcSEcCtD
Paclitaxel—Dyspnoea—Temozolomide—skin cancer	1.48e-05	0.000347	CcSEcCtD
Paclitaxel—Somnolence—Temozolomide—skin cancer	1.47e-05	0.000346	CcSEcCtD
Paclitaxel—Erythema multiforme—Docetaxel—skin cancer	1.46e-05	0.000345	CcSEcCtD
Paclitaxel—Dyspepsia—Temozolomide—skin cancer	1.46e-05	0.000343	CcSEcCtD
Paclitaxel—Anorexia—Fluorouracil—skin cancer	1.45e-05	0.000342	CcSEcCtD
Paclitaxel—Eye disorder—Docetaxel—skin cancer	1.45e-05	0.000341	CcSEcCtD
Paclitaxel—Abdominal pain—Dactinomycin—skin cancer	1.45e-05	0.000341	CcSEcCtD
Paclitaxel—Body temperature increased—Dactinomycin—skin cancer	1.45e-05	0.000341	CcSEcCtD
Paclitaxel—Hypersensitivity—Bleomycin—skin cancer	1.45e-05	0.00034	CcSEcCtD
Paclitaxel—Decreased appetite—Temozolomide—skin cancer	1.44e-05	0.000339	CcSEcCtD
Paclitaxel—Flushing—Docetaxel—skin cancer	1.44e-05	0.000339	CcSEcCtD
Paclitaxel—Cardiac disorder—Docetaxel—skin cancer	1.44e-05	0.000339	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Temozolomide—skin cancer	1.43e-05	0.000336	CcSEcCtD
Paclitaxel—Fatigue—Temozolomide—skin cancer	1.43e-05	0.000336	CcSEcCtD
Paclitaxel—Hypotension—Fluorouracil—skin cancer	1.42e-05	0.000336	CcSEcCtD
Paclitaxel—Pain—Temozolomide—skin cancer	1.42e-05	0.000333	CcSEcCtD
Paclitaxel—Constipation—Temozolomide—skin cancer	1.42e-05	0.000333	CcSEcCtD
Paclitaxel—Asthenia—Bleomycin—skin cancer	1.41e-05	0.000331	CcSEcCtD
Paclitaxel—Angiopathy—Docetaxel—skin cancer	1.41e-05	0.000331	CcSEcCtD
Paclitaxel—Immune system disorder—Docetaxel—skin cancer	1.4e-05	0.000329	CcSEcCtD
Paclitaxel—Mediastinal disorder—Docetaxel—skin cancer	1.4e-05	0.000329	CcSEcCtD
Paclitaxel—Chills—Docetaxel—skin cancer	1.39e-05	0.000327	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Fluorouracil—skin cancer	1.39e-05	0.000327	CcSEcCtD
Paclitaxel—Pruritus—Bleomycin—skin cancer	1.39e-05	0.000327	CcSEcCtD
Paclitaxel—Arrhythmia—Docetaxel—skin cancer	1.38e-05	0.000326	CcSEcCtD
Paclitaxel—Insomnia—Fluorouracil—skin cancer	1.38e-05	0.000325	CcSEcCtD
Paclitaxel—MAPT—LKB1 signaling events—TP53—skin cancer	1.38e-05	0.00675	CbGpPWpGaD
Paclitaxel—Paraesthesia—Fluorouracil—skin cancer	1.37e-05	0.000322	CcSEcCtD
Paclitaxel—Alopecia—Docetaxel—skin cancer	1.37e-05	0.000322	CcSEcCtD
Paclitaxel—Feeling abnormal—Temozolomide—skin cancer	1.36e-05	0.000321	CcSEcCtD
Paclitaxel—Dyspnoea—Fluorouracil—skin cancer	1.36e-05	0.00032	CcSEcCtD
Paclitaxel—Mental disorder—Docetaxel—skin cancer	1.36e-05	0.00032	CcSEcCtD
Paclitaxel—Somnolence—Fluorouracil—skin cancer	1.36e-05	0.000319	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Temozolomide—skin cancer	1.35e-05	0.000319	CcSEcCtD
Paclitaxel—Malnutrition—Docetaxel—skin cancer	1.35e-05	0.000318	CcSEcCtD
Paclitaxel—Erythema—Docetaxel—skin cancer	1.35e-05	0.000318	CcSEcCtD
Paclitaxel—Hypersensitivity—Dactinomycin—skin cancer	1.35e-05	0.000317	CcSEcCtD
Paclitaxel—MAPT—IL-2 Signaling Pathway—HRAS—skin cancer	1.34e-05	0.00658	CbGpPWpGaD
Paclitaxel—Dyspepsia—Fluorouracil—skin cancer	1.34e-05	0.000316	CcSEcCtD
Paclitaxel—ABCB1—lymph node—skin cancer	1.34e-05	0.00106	CbGeAlD
Paclitaxel—TUBB6—Metabolism of proteins—EXOC2—skin cancer	1.34e-05	0.00654	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—EXOC2—skin cancer	1.34e-05	0.00654	CbGpPWpGaD
Paclitaxel—Decreased appetite—Fluorouracil—skin cancer	1.33e-05	0.000312	CcSEcCtD
Paclitaxel—Dysgeusia—Docetaxel—skin cancer	1.32e-05	0.000311	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Fluorouracil—skin cancer	1.32e-05	0.00031	CcSEcCtD
Paclitaxel—Urticaria—Temozolomide—skin cancer	1.31e-05	0.00031	CcSEcCtD
Paclitaxel—Asthenia—Dactinomycin—skin cancer	1.31e-05	0.000309	CcSEcCtD
Paclitaxel—BCL2—Activation of BH3-only proteins—TP53—skin cancer	1.31e-05	0.00641	CbGpPWpGaD
Paclitaxel—Body temperature increased—Temozolomide—skin cancer	1.31e-05	0.000308	CcSEcCtD
Paclitaxel—Abdominal pain—Temozolomide—skin cancer	1.31e-05	0.000308	CcSEcCtD
Paclitaxel—Back pain—Docetaxel—skin cancer	1.3e-05	0.000307	CcSEcCtD
Paclitaxel—Pain—Fluorouracil—skin cancer	1.3e-05	0.000307	CcSEcCtD
Paclitaxel—Muscle spasms—Docetaxel—skin cancer	1.3e-05	0.000305	CcSEcCtD
Paclitaxel—TUBB3—Metabolism of proteins—EXOC2—skin cancer	1.29e-05	0.00632	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Fluorouracil—skin cancer	1.26e-05	0.000296	CcSEcCtD
Paclitaxel—Diarrhoea—Dactinomycin—skin cancer	1.25e-05	0.000295	CcSEcCtD
Paclitaxel—TUBB2A—Metabolism of proteins—EXOC2—skin cancer	1.25e-05	0.00612	CbGpPWpGaD
Paclitaxel—Vomiting—Bleomycin—skin cancer	1.25e-05	0.000294	CcSEcCtD
Paclitaxel—Anaemia—Docetaxel—skin cancer	1.25e-05	0.000294	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	1.24e-05	0.00607	CbGpPWpGaD
Paclitaxel—Rash—Bleomycin—skin cancer	1.24e-05	0.000291	CcSEcCtD
Paclitaxel—Dermatitis—Bleomycin—skin cancer	1.24e-05	0.000291	CcSEcCtD
Paclitaxel—TUBB1—Metabolism of proteins—EXOC2—skin cancer	1.22e-05	0.00598	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Temozolomide—skin cancer	1.22e-05	0.000287	CcSEcCtD
Paclitaxel—Urticaria—Fluorouracil—skin cancer	1.21e-05	0.000285	CcSEcCtD
Paclitaxel—Syncope—Docetaxel—skin cancer	1.21e-05	0.000285	CcSEcCtD
Paclitaxel—Leukopenia—Docetaxel—skin cancer	1.21e-05	0.000284	CcSEcCtD
Paclitaxel—Body temperature increased—Fluorouracil—skin cancer	1.21e-05	0.000284	CcSEcCtD
Paclitaxel—Palpitations—Docetaxel—skin cancer	1.19e-05	0.000281	CcSEcCtD
Paclitaxel—Asthenia—Temozolomide—skin cancer	1.19e-05	0.00028	CcSEcCtD
Paclitaxel—Loss of consciousness—Docetaxel—skin cancer	1.19e-05	0.000279	CcSEcCtD
Paclitaxel—MAPT—Copper homeostasis—TP53—skin cancer	1.18e-05	0.0058	CbGpPWpGaD
Paclitaxel—Cough—Docetaxel—skin cancer	1.18e-05	0.000277	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.18e-05	0.00576	CbGpPWpGaD
Paclitaxel—Pruritus—Temozolomide—skin cancer	1.17e-05	0.000276	CcSEcCtD
Paclitaxel—Convulsion—Docetaxel—skin cancer	1.17e-05	0.000275	CcSEcCtD
Paclitaxel—Nausea—Bleomycin—skin cancer	1.17e-05	0.000274	CcSEcCtD
Paclitaxel—Hypertension—Docetaxel—skin cancer	1.16e-05	0.000274	CcSEcCtD
Paclitaxel—Vomiting—Dactinomycin—skin cancer	1.16e-05	0.000274	CcSEcCtD
Paclitaxel—Rash—Dactinomycin—skin cancer	1.15e-05	0.000272	CcSEcCtD
Paclitaxel—Myalgia—Docetaxel—skin cancer	1.15e-05	0.00027	CcSEcCtD
Paclitaxel—Chest pain—Docetaxel—skin cancer	1.15e-05	0.00027	CcSEcCtD
Paclitaxel—Arthralgia—Docetaxel—skin cancer	1.15e-05	0.00027	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	1.14e-05	0.000268	CcSEcCtD
Paclitaxel—Diarrhoea—Temozolomide—skin cancer	1.13e-05	0.000267	CcSEcCtD
Paclitaxel—Hypersensitivity—Fluorouracil—skin cancer	1.12e-05	0.000265	CcSEcCtD
Paclitaxel—Dry mouth—Docetaxel—skin cancer	1.12e-05	0.000264	CcSEcCtD
Paclitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—skin cancer	1.12e-05	0.00549	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.11e-05	0.00546	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.11e-05	0.00546	CbGpPWpGaD
Paclitaxel—Confusional state—Docetaxel—skin cancer	1.11e-05	0.000261	CcSEcCtD
Paclitaxel—Oedema—Docetaxel—skin cancer	1.1e-05	0.000259	CcSEcCtD
Paclitaxel—Anaphylactic shock—Docetaxel—skin cancer	1.1e-05	0.000259	CcSEcCtD
Paclitaxel—TUBB4A—Metabolism of proteins—EXOC2—skin cancer	1.1e-05	0.00537	CbGpPWpGaD
Paclitaxel—Dizziness—Temozolomide—skin cancer	1.09e-05	0.000258	CcSEcCtD
Paclitaxel—Infection—Docetaxel—skin cancer	1.09e-05	0.000257	CcSEcCtD
Paclitaxel—Nausea—Dactinomycin—skin cancer	1.09e-05	0.000256	CcSEcCtD
Paclitaxel—Shock—Docetaxel—skin cancer	1.08e-05	0.000255	CcSEcCtD
Paclitaxel—Nervous system disorder—Docetaxel—skin cancer	1.08e-05	0.000254	CcSEcCtD
Paclitaxel—Pruritus—Fluorouracil—skin cancer	1.08e-05	0.000254	CcSEcCtD
Paclitaxel—Thrombocytopenia—Docetaxel—skin cancer	1.08e-05	0.000254	CcSEcCtD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.08e-05	0.00527	CbGpPWpGaD
Paclitaxel—Tachycardia—Docetaxel—skin cancer	1.07e-05	0.000253	CcSEcCtD
Paclitaxel—Skin disorder—Docetaxel—skin cancer	1.07e-05	0.000252	CcSEcCtD
Paclitaxel—Vomiting—Temozolomide—skin cancer	1.05e-05	0.000248	CcSEcCtD
Paclitaxel—Anorexia—Docetaxel—skin cancer	1.05e-05	0.000247	CcSEcCtD
Paclitaxel—Rash—Temozolomide—skin cancer	1.04e-05	0.000246	CcSEcCtD
Paclitaxel—Diarrhoea—Fluorouracil—skin cancer	1.04e-05	0.000246	CcSEcCtD
Paclitaxel—Dermatitis—Temozolomide—skin cancer	1.04e-05	0.000245	CcSEcCtD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.04e-05	0.0051	CbGpPWpGaD
Paclitaxel—Headache—Temozolomide—skin cancer	1.04e-05	0.000244	CcSEcCtD
Paclitaxel—Hypotension—Docetaxel—skin cancer	1.03e-05	0.000242	CcSEcCtD
Paclitaxel—BCL2—EPO signaling pathway—HRAS—skin cancer	1.03e-05	0.00503	CbGpPWpGaD
Paclitaxel—MAPT—Kit receptor signaling pathway—HRAS—skin cancer	1.02e-05	0.00501	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.02e-05	0.00499	CbGpPWpGaD
Paclitaxel—BCL2—IL-5 Signaling Pathway—KRAS—skin cancer	1.01e-05	0.00495	CbGpPWpGaD
Paclitaxel—Dizziness—Fluorouracil—skin cancer	1.01e-05	0.000237	CcSEcCtD
Paclitaxel—TUBB4B—Metabolism of proteins—EXOC2—skin cancer	1e-05	0.00491	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MSH2—skin cancer	1e-05	0.00491	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Docetaxel—skin cancer	1e-05	0.000236	CcSEcCtD
Paclitaxel—Insomnia—Docetaxel—skin cancer	9.95e-06	0.000234	CcSEcCtD
Paclitaxel—Paraesthesia—Docetaxel—skin cancer	9.88e-06	0.000233	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	9.83e-06	0.00481	CbGpPWpGaD
Paclitaxel—Nausea—Temozolomide—skin cancer	9.83e-06	0.000231	CcSEcCtD
Paclitaxel—Dyspnoea—Docetaxel—skin cancer	9.81e-06	0.000231	CcSEcCtD
Paclitaxel—Somnolence—Docetaxel—skin cancer	9.78e-06	0.00023	CcSEcCtD
Paclitaxel—Vomiting—Fluorouracil—skin cancer	9.69e-06	0.000228	CcSEcCtD
Paclitaxel—Dyspepsia—Docetaxel—skin cancer	9.69e-06	0.000228	CcSEcCtD
Paclitaxel—MAPT—MAPK Signaling Pathway—BRAF—skin cancer	9.64e-06	0.00472	CbGpPWpGaD
Paclitaxel—Rash—Fluorouracil—skin cancer	9.61e-06	0.000226	CcSEcCtD
Paclitaxel—Dermatitis—Fluorouracil—skin cancer	9.6e-06	0.000226	CcSEcCtD
Paclitaxel—BCL2—Corticotropin-releasing hormone—BRAF—skin cancer	9.6e-06	0.0047	CbGpPWpGaD
Paclitaxel—MAPT—LPA receptor mediated events—HRAS—skin cancer	9.59e-06	0.0047	CbGpPWpGaD
Paclitaxel—Decreased appetite—Docetaxel—skin cancer	9.57e-06	0.000225	CcSEcCtD
Paclitaxel—Headache—Fluorouracil—skin cancer	9.55e-06	0.000225	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Docetaxel—skin cancer	9.5e-06	0.000224	CcSEcCtD
Paclitaxel—Fatigue—Docetaxel—skin cancer	9.49e-06	0.000223	CcSEcCtD
Paclitaxel—Pain—Docetaxel—skin cancer	9.41e-06	0.000222	CcSEcCtD
Paclitaxel—Constipation—Docetaxel—skin cancer	9.41e-06	0.000222	CcSEcCtD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—skin cancer	9.36e-06	0.00458	CbGpPWpGaD
Paclitaxel—BCL2—Intrinsic Pathway for Apoptosis—TP53—skin cancer	9.36e-06	0.00458	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—NRAS—skin cancer	9.24e-06	0.00452	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—SLC12A2—skin cancer	9.15e-06	0.00448	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Docetaxel—skin cancer	9.07e-06	0.000214	CcSEcCtD
Paclitaxel—Nausea—Fluorouracil—skin cancer	9.06e-06	0.000213	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Docetaxel—skin cancer	9e-06	0.000212	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—CDKN2A—skin cancer	8.92e-06	0.00436	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—CDKN2A—skin cancer	8.92e-06	0.00436	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	8.72e-06	0.00427	CbGpPWpGaD
Paclitaxel—Body temperature increased—Docetaxel—skin cancer	8.7e-06	0.000205	CcSEcCtD
Paclitaxel—Abdominal pain—Docetaxel—skin cancer	8.7e-06	0.000205	CcSEcCtD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—BRAF—skin cancer	8.63e-06	0.00423	CbGpPWpGaD
Paclitaxel—MAPT—Alzheimers Disease—TP53—skin cancer	8.47e-06	0.00415	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.39e-06	0.00411	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.37e-06	0.0041	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—CDKN2A—skin cancer	8.36e-06	0.00409	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—PTGS2—skin cancer	8.34e-06	0.00408	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Cancer Pathway—TP53—skin cancer	8.32e-06	0.00407	CbGpPWpGaD
Paclitaxel—BCL2—IL-2 Signaling Pathway—HRAS—skin cancer	8.26e-06	0.00404	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	8.19e-06	0.00401	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Docetaxel—skin cancer	8.11e-06	0.000191	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—TLR7—skin cancer	8.11e-06	0.00397	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL6—skin cancer	8.03e-06	0.00393	CbGpPWpGaD
Paclitaxel—BCL2—Interleukin-11 Signaling Pathway—HRAS—skin cancer	7.96e-06	0.0039	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—KRAS—skin cancer	7.95e-06	0.00389	CbGpPWpGaD
Paclitaxel—ABCC1—Arachidonic acid metabolism—PTGS2—skin cancer	7.92e-06	0.00388	CbGpPWpGaD
Paclitaxel—Asthenia—Docetaxel—skin cancer	7.9e-06	0.000186	CcSEcCtD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.89e-06	0.00386	CbGpPWpGaD
Paclitaxel—Pruritus—Docetaxel—skin cancer	7.79e-06	0.000183	CcSEcCtD
Paclitaxel—CYP1B1—Arachidonic acid metabolism—PTGS2—skin cancer	7.66e-06	0.00375	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.56e-06	0.0037	CbGpPWpGaD
Paclitaxel—Diarrhoea—Docetaxel—skin cancer	7.53e-06	0.000177	CcSEcCtD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—CDKN2A—skin cancer	7.46e-06	0.00365	CbGpPWpGaD
Paclitaxel—BCL2—IL-3 Signaling Pathway—HRAS—skin cancer	7.3e-06	0.00358	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CDK4—skin cancer	7.3e-06	0.00357	CbGpPWpGaD
Paclitaxel—Dizziness—Docetaxel—skin cancer	7.28e-06	0.000171	CcSEcCtD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—skin cancer	7.24e-06	0.00354	CbGpPWpGaD
Paclitaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—skin cancer	7.07e-06	0.00346	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.03e-06	0.00344	CbGpPWpGaD
Paclitaxel—Vomiting—Docetaxel—skin cancer	7e-06	0.000165	CcSEcCtD
Paclitaxel—Rash—Docetaxel—skin cancer	6.94e-06	0.000163	CcSEcCtD
Paclitaxel—Dermatitis—Docetaxel—skin cancer	6.93e-06	0.000163	CcSEcCtD
Paclitaxel—Headache—Docetaxel—skin cancer	6.89e-06	0.000162	CcSEcCtD
Paclitaxel—BCL2—IL2-mediated signaling events—HRAS—skin cancer	6.76e-06	0.00331	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MLH1—skin cancer	6.67e-06	0.00327	CbGpPWpGaD
Paclitaxel—Nausea—Docetaxel—skin cancer	6.54e-06	0.000154	CcSEcCtD
Paclitaxel—BCL2—C-MYB transcription factor network—NRAS—skin cancer	6.49e-06	0.00318	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—BRAF—skin cancer	6.46e-06	0.00316	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	6.37e-06	0.00312	CbGpPWpGaD
Paclitaxel—BCL2—Kit receptor signaling pathway—HRAS—skin cancer	6.29e-06	0.00308	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—NRAS—skin cancer	6.06e-06	0.00297	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	6.05e-06	0.00296	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—IL6—skin cancer	6.02e-06	0.00295	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.96e-06	0.00292	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.93e-06	0.0029	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	5.78e-06	0.00283	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.74e-06	0.00281	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—KRAS—skin cancer	5.58e-06	0.00273	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MLH1—skin cancer	5.53e-06	0.00271	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	5.48e-06	0.00268	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.41e-06	0.00265	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—BRAF—skin cancer	5.37e-06	0.00263	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.35e-06	0.00262	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—NRAS—skin cancer	5.27e-06	0.00258	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—KRAS—skin cancer	5.21e-06	0.00255	CbGpPWpGaD
Paclitaxel—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	5.08e-06	0.00249	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MLH1—skin cancer	5.06e-06	0.00248	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—HRAS—skin cancer	5.01e-06	0.00245	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—skin cancer	4.96e-06	0.00243	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TP53—skin cancer	4.94e-06	0.00242	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—HRAS—skin cancer	4.74e-06	0.00232	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TLR7—skin cancer	4.72e-06	0.00231	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	4.72e-06	0.00231	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	4.71e-06	0.0023	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.7e-06	0.0023	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	4.66e-06	0.00228	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—skin cancer	4.65e-06	0.00228	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—skin cancer	4.63e-06	0.00227	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CDK4—skin cancer	4.6e-06	0.00225	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—KRAS—skin cancer	4.53e-06	0.00222	CbGpPWpGaD
Paclitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	4.32e-06	0.00212	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.32e-06	0.00212	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.18e-06	0.00205	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—FOXO4—skin cancer	4.18e-06	0.00204	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—skin cancer	4.15e-06	0.00203	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—BRAF—skin cancer	4.07e-06	0.00199	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—skin cancer	4.03e-06	0.00197	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—HRAS—skin cancer	3.97e-06	0.00194	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—HRAS—skin cancer	3.85e-06	0.00189	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IL6—skin cancer	3.8e-06	0.00186	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CDK4—skin cancer	3.79e-06	0.00186	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TERT—skin cancer	3.79e-06	0.00185	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PLIN2—skin cancer	3.74e-06	0.00183	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.7e-06	0.00181	CbGpPWpGaD
Paclitaxel—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	3.52e-06	0.00172	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PLIN2—skin cancer	3.52e-06	0.00172	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	3.51e-06	0.00172	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—KRAS—skin cancer	3.49e-06	0.00171	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CDK4—skin cancer	3.39e-06	0.00166	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—skin cancer	3.3e-06	0.00161	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.24e-06	0.00159	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CDK4—skin cancer	3.14e-06	0.00154	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TERT—skin cancer	3.14e-06	0.00154	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—skin cancer	3.1e-06	0.00152	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—skin cancer	3.04e-06	0.00149	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CSPG4—skin cancer	3.01e-06	0.00147	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CDKN2A—skin cancer	2.9e-06	0.00142	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.89e-06	0.00142	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CDK4—skin cancer	2.87e-06	0.00141	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TERT—skin cancer	2.87e-06	0.00141	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CSPG4—skin cancer	2.83e-06	0.00139	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CDK4—skin cancer	2.81e-06	0.00138	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—ERCC2—skin cancer	2.74e-06	0.00134	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PLIN2—skin cancer	2.65e-06	0.0013	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PLIN2—skin cancer	2.64e-06	0.00129	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.64e-06	0.00129	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CDKN2A—skin cancer	2.59e-06	0.00127	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.57e-06	0.00126	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CDK4—skin cancer	2.57e-06	0.00126	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PLIN2—skin cancer	2.55e-06	0.00125	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.54e-06	0.00125	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CSPG4—skin cancer	2.54e-06	0.00124	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HRAS—skin cancer	2.47e-06	0.00121	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—FOXO4—skin cancer	2.43e-06	0.00119	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—skin cancer	2.4e-06	0.00118	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PLIN2—skin cancer	2.32e-06	0.00114	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PLIN2—skin cancer	2.3e-06	0.00113	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—skin cancer	2.2e-06	0.00108	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—skin cancer	2.2e-06	0.00108	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CDKN2A—skin cancer	2.15e-06	0.00105	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CSPG4—skin cancer	2.14e-06	0.00105	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CSPG4—skin cancer	2.13e-06	0.00104	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CSPG4—skin cancer	2.06e-06	0.00101	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ENO2—skin cancer	2.05e-06	0.001	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CDKN2A—skin cancer	1.96e-06	0.000962	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.96e-06	0.000957	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ENO2—skin cancer	1.93e-06	0.000943	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CSPG4—skin cancer	1.87e-06	0.000917	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CSPG4—skin cancer	1.86e-06	0.000909	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.8e-06	0.000883	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ENO2—skin cancer	1.73e-06	0.000846	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SHH—skin cancer	1.73e-06	0.000846	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PLIN2—skin cancer	1.67e-06	0.000815	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.6e-06	0.000784	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.51e-06	0.000738	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ENO2—skin cancer	1.45e-06	0.000712	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ENO2—skin cancer	1.45e-06	0.000708	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—skin cancer	1.44e-06	0.000706	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PLIN2—skin cancer	1.44e-06	0.000706	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FOXO4—skin cancer	1.41e-06	0.00069	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ENO2—skin cancer	1.4e-06	0.000685	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—skin cancer	1.39e-06	0.00068	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CSPG4—skin cancer	1.34e-06	0.000657	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.29e-06	0.000631	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ENO2—skin cancer	1.27e-06	0.000623	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ENO2—skin cancer	1.26e-06	0.000618	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLIN2—skin cancer	1.26e-06	0.000615	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—skin cancer	1.2e-06	0.000585	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—skin cancer	1.19e-06	0.000585	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ERCC2—skin cancer	1.19e-06	0.000582	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLIN2—skin cancer	1.17e-06	0.000575	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CSPG4—skin cancer	1.16e-06	0.000569	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.14e-06	0.000556	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.13e-06	0.000554	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ERCC2—skin cancer	1.12e-06	0.000548	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.09e-06	0.000536	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—skin cancer	1.09e-06	0.000535	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—skin cancer	1.02e-06	0.000497	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CSPG4—skin cancer	1.01e-06	0.000496	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERCC2—skin cancer	1e-06	0.000491	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—skin cancer	9.72e-07	0.000476	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CSPG4—skin cancer	9.46e-07	0.000463	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TERT—skin cancer	9.41e-07	0.000461	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ENO2—skin cancer	9.12e-07	0.000447	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	8.63e-07	0.000423	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ERCC2—skin cancer	8.44e-07	0.000413	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ERCC2—skin cancer	8.41e-07	0.000412	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ERCC2—skin cancer	8.13e-07	0.000398	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—skin cancer	8.09e-07	0.000396	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ENO2—skin cancer	7.9e-07	0.000387	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLIN2—skin cancer	7.74e-07	0.000379	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	7.67e-07	0.000376	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—skin cancer	7.45e-07	0.000365	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ERCC2—skin cancer	7.4e-07	0.000362	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ERCC2—skin cancer	7.33e-07	0.000359	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—skin cancer	7.13e-07	0.000349	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—skin cancer	6.96e-07	0.000341	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO2—skin cancer	6.88e-07	0.000337	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—skin cancer	6.71e-07	0.000328	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO2—skin cancer	6.43e-07	0.000315	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CSPG4—skin cancer	6.24e-07	0.000305	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.18e-07	0.000303	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—skin cancer	6.02e-07	0.000295	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—skin cancer	5.92e-07	0.00029	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—skin cancer	5.66e-07	0.000277	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ERCC2—skin cancer	5.3e-07	0.000259	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—skin cancer	5.06e-07	0.000248	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—skin cancer	5.04e-07	0.000247	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.03e-07	0.000246	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—skin cancer	4.87e-07	0.000239	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—skin cancer	4.68e-07	0.000229	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ERCC2—skin cancer	4.59e-07	0.000225	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—skin cancer	4.43e-07	0.000217	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—skin cancer	4.4e-07	0.000215	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO2—skin cancer	4.24e-07	0.000208	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—skin cancer	4.03e-07	0.000197	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ERCC2—skin cancer	4e-07	0.000196	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ERCC2—skin cancer	3.74e-07	0.000183	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—skin cancer	3.43e-07	0.000168	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—skin cancer	3.28e-07	0.000161	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—skin cancer	3.18e-07	0.000156	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—skin cancer	2.75e-07	0.000135	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ERCC2—skin cancer	2.46e-07	0.000121	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—skin cancer	2.4e-07	0.000117	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—skin cancer	2.24e-07	0.00011	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—skin cancer	1.48e-07	7.23e-05	CbGpPWpGaD
